Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
151
-
Total 13F shares, excl. options
-
6.45M
-
Shares change
-
+1.27M
-
Total reported value, excl. options
-
$319M
-
Value change
-
+$59.8M
-
Put/Call ratio
-
6.73
-
Number of buys
-
91
-
Number of sells
-
-60
-
Price
-
$49.51
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2017
188 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q1 2017.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.45M shares
of 22.3M outstanding shares and own 28.97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.13M shares), VANGUARD GROUP INC (441K shares), GLENMEDE TRUST CO NA (399K shares), STATE STREET CORP (304K shares), FIRST MANHATTAN CO (278K shares), RENAISSANCE TECHNOLOGIES LLC (278K shares), PERCEPTIVE ADVISORS LLC (255K shares), NOMURA HOLDINGS INC (209K shares), BANK OF AMERICA CORP /DE/ (197K shares), and DIMENSIONAL FUND ADVISORS LP (178K shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.